See the Full Picture.
Published loading...Updated

Study finds a treatment more effective than Ozempic for slimming down

Summary by Australian Financial Review
The analysis found a rival drug made by Eli Lilly leads to faster and better weight loss, causing shares in to Wegovy maker Novo Nordisk’s to also drop.

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Australian Financial Review broke the news in Sydney, Australia on Wednesday, July 10, 2024.
Sources are mostly out of (0)